The lung microbiome during health and disease
K Yagi, GB Huffnagle, NW Lukacs, N Asai - International journal of …, 2021 - mdpi.com
Healthy human lungs have traditionally been considered to be a sterile organ. However,
culture-independent molecular techniques have reported that large numbers of microbes …
culture-independent molecular techniques have reported that large numbers of microbes …
Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity
Bronchiectasis is characterised by pathological dilation of the airways. More specifically, the
radiographic demonstration of airway enlargement is the common feature of a …
radiographic demonstration of airway enlargement is the common feature of a …
European Respiratory Society guidelines for the management of adult bronchiectasis
E Polverino, PC Goeminne… - European …, 2017 - Eur Respiratory Soc
Bronchiectasis in adults is a chronic disorder associated with poor quality of life and frequent
exacerbations in many patients. There have been no previous international guidelines. The …
exacerbations in many patients. There have been no previous international guidelines. The …
Bronchiectasis
JD Chalmers, AB Chang, SH Chotirmall… - Nature reviews Disease …, 2018 - nature.com
Bronchiectasis refers to abnormal dilatation of the bronchi. Airway dilatation can lead to
failure of mucus clearance and increased risk of infection. Pathophysiological mechanisms …
failure of mucus clearance and increased risk of infection. Pathophysiological mechanisms …
A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis
S Finch, MJ McDonnell, H Abo-Leyah… - Annals of the …, 2015 - atsjournals.org
Rationale: Eradication and suppression of Pseudomonas aeruginosa is a key priority in
national guidelines for bronchiectasis and is a major focus of drug development and clinical …
national guidelines for bronchiectasis and is a major focus of drug development and clinical …
Characterization of the “frequent exacerbator phenotype” in bronchiectasis
JD Chalmers, S Aliberti, A Filonenko… - American journal of …, 2018 - atsjournals.org
Rationale: Exacerbations are key events in the natural history of bronchiectasis, but clinical
predictors and outcomes of patients with frequently exacerbating disease are not well …
predictors and outcomes of patients with frequently exacerbating disease are not well …
Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis
JD Chalmers, KL Moffitt, G Suarez-Cuartin… - American journal of …, 2017 - atsjournals.org
Rationale: Sputum neutrophil elastase and serum desmosine, which is a linked marker of
endogenous elastin degradation, are possible biomarkers of disease severity and …
endogenous elastin degradation, are possible biomarkers of disease severity and …
Co‐morbidities in severe asthma: C linical impact and management
C Porsbjerg, A Menzies‐Gow - Respirology, 2017 - Wiley Online Library
Patients with severe asthma represent a minority of the total asthma population, but carry a
majority of the morbidity and healthcare costs. Achieving better asthma control in this group …
majority of the morbidity and healthcare costs. Achieving better asthma control in this group …
Clinical phenotypes in adult patients with bronchiectasis
S Aliberti, S Lonni, S Dore… - European …, 2016 - Eur Respiratory Soc
Bronchiectasis is a heterogeneous disease. This study aimed at identifying discrete groups
of patients with different clinical and biological characteristics and long-term outcomes. This …
of patients with different clinical and biological characteristics and long-term outcomes. This …
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
T Aksamit, A De Soyza, TJ Bandel… - European …, 2018 - Eur Respiratory Soc
We evaluated the efficacy and safety of ciprofloxacin dry powder for inhalation (DPI) in
patients with non-cystic fibrosis bronchiectasis, two or more exacerbations in the previous …
patients with non-cystic fibrosis bronchiectasis, two or more exacerbations in the previous …